M.D. Minden
- Hematology top 10%
- Acute Myeloid Leukemia Research 8
- Chronic Myeloid Leukemia Treatments 3
-
- Cancer Genomics and Diagnostics 2
-
- Glycosylation and Glycoproteins Research 1
- Advanced Biosensing Techniques and Applications 1
-
- T-cell and Retrovirus Studies 1
-
- Acute Lymphoblastic Leukemia research 4
-
- Neutropenia and Cancer Infections 1
- Co-authors
- E. A. McCullochJim DimitroulakosZhenlei XiaW. Wei‐Lynn WongLinda Z. PennGuisheng YangZhenbo HuSergey Krysov
- Partner nations
- CanadaUnited StatesNetherlands
In The Last Decade
M.D. Minden
15 papers receiving 278 citations
Peers
Comparison fields: 5 of 56
- Hematology 86
- Cancer Research 87
- Molecular Biology 152
- Genetics 22
- Immunology 41
Countries citing papers authored by M.D. Minden
This map shows the geographic impact of M.D. Minden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.D. Minden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.D. Minden more than expected).
Fields of papers citing papers by M.D. Minden
This network shows the impact of papers produced by M.D. Minden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.D. Minden. The network helps show where M.D. Minden may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M.D. Minden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 1 | |
| 2 | 2017 | 1 | |
| 3 | 2017 | 1 | |
| 4 | 2015 | 53 | |
| 5 | 2010 | 1 | |
| 6 | 2009 | 1 | |
| 7 | 2004 | 2 | |
| 8 | 2003 | 6 | |
| 9 | 2001 | 113 | |
| 10 | Regulation of the synthesis of bcl-2 protein by growth factors. | 1996 | 16 |
| 11 | Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals. | 1995 | 47 |
| 12 | Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia. | 1994 | 27 |
| 13 | High-dose cytosine arabinoside remission induction for acute myelogenous leukemia: comparison of two regimens of remission maintenance. | 1992 | 6 |
| 14 | The influence of growth regulation on treatment strategy for acute myeloblastic leukaemia. | 1990 | 7 |
| 15 | 1987 | 2 | |
| 16 | 1986 | 5 |
About M.D. Minden
M.D. Minden is a scholar working on Hematology, Cancer Research, Genetics, Public Health, Environmental and Occupational Health and Oncology, having authored 16 papers that have together received 289 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Cancer Genomics and Diagnostics (2 papers), Glycosylation and Glycoproteins Research (1 paper), Neutropenia and Cancer Infections (1 paper), Advanced Biosensing Techniques and Applications (1 paper) and T-cell and Retrovirus Studies (1 paper). The work is most often cited by research in Hematology (86 citations), Cancer Research (87 citations), Molecular Biology (152 citations), Genetics (22 citations) and Immunology (41 citations). M.D. Minden has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include E. A. McCulloch, Jim Dimitroulakos, Zhenlei Xia, W. Wei‐Lynn Wong, Linda Z. Penn, Guisheng Yang, Zhenbo Hu, Sergey Krysov, Katja Zirlik and Graham Packham. Their work appears in journals such as Journal of Clinical Oncology, Leukemia Research, Blood, Stem Cells and Acta Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.